Cell No. : Cell Name RCB0411 : HaP-T1  update : 2024/11/14
Comment			Mucin producing, BHP-induced pancreatic tumor
Comment from the depositor
Terms and conditions			There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Remarks
Order Form			Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Depositor	Saito, Seiji
		Originator	Saito, Seiji
		Year of deposit	1989
		Animal	_hamster < Mammals
		Strain name	Syrian
		Genus	Mesocricetus
		Species	auratus
		Gender	Female
		Age at sampling	28 weeks
		Tissue	pancreas
		Disease name	pancreatic tumor, BHP-induced
		Classification	cancer
		Year of origin	1983
		Lifespan	infinite
		Morphology	epithelial-like
		Cellosaurus(Expasy)	CVCL_2054
			deposit info	lot info
		Medium	Medium List
		Culture type		Adherent cells
		Culture medium		MEM + 10% FBS + 1mM Sodium Pyruvate + 0.1mM NEAA
		Antibiotics		Free
		Passage method		0.25% Trypsin
	Culture information	Passage ratio		1 : 8 split
		SC frequency		Subculture : 2 times/week
		Temperature		37 ℃
		CO2 concentration		5 %
		Freeze medium		Medium + 10% DMSO
		Freezing method		Slow freezing
		Mycoplasma/Acholeplasma		(-)
		Animal PCR		OK
		Isozyme		LD, NP
Images			deposit info	lot info
Reference information		Reference	1
		User's Publication	4

Top

Reference

1091  Saito S, Nishimura N, Kubota Y, Yamazaki K, Shibuya T, Sasaki H  Establishment and characterization of a cultured cell line derived from nitrosamine-induced pancreatic ductal adenocarcinoma in Syrian golden hamsters.  Gastroenterol Jpn  1988  23:183-94  PubMed ID: 2838375   DOI: 10.1007/bf02799031

Top

User's Publication

21819  Kawakami H, Ijichi N, Obama Y, Matsuda E, Mitsui K, Nishikawaji Y, Watanabe M, Nagano S, Taniguchi N, Komiya S, Kosai KI.  An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy.  Transl Res  2024    PubMed ID: 38969167   DOI: 10.1016/j.trsl.2024.07.002

7292  Watanabe M.  A novel in situ permeation system and its utility in cancer tissue ablation.  Int. J. Oncol.  2015  47:875-83  PubMed ID: 26134633   DOI: 10.3892/ijo.2015.3068

18673  Takahashi M, Kitahashi T, Ishigamori R, Mutoh M, Komiya M, Sato H, Kamanaka Y, Naka M, Maruyama T, Sugimura T, Wakabayashi K.  Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor  Carcinogenesis  2008  29(8):1608-13  PubMed ID: 18567618   DOI: 10.1093/carcin/bgn152

17364  Himeno Y, Etoh T, Matsumoto T, Ohta M, Nishizono A, Kitano S.  Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models  Int J Oncol  2005  27(4):901-6  PubMed ID: 16142304